IL133143A0 - Treatment of diabetes with rosiglitazone and insulin - Google Patents
Treatment of diabetes with rosiglitazone and insulinInfo
- Publication number
- IL133143A0 IL133143A0 IL13314398A IL13314398A IL133143A0 IL 133143 A0 IL133143 A0 IL 133143A0 IL 13314398 A IL13314398 A IL 13314398A IL 13314398 A IL13314398 A IL 13314398A IL 133143 A0 IL133143 A0 IL 133143A0
- Authority
- IL
- Israel
- Prior art keywords
- rosiglitazone
- insulin
- diabetes
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9712866.4A GB9712866D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
| PCT/EP1998/003692 WO1998057636A1 (en) | 1997-06-18 | 1998-06-15 | Treatment of diabetes with rosiglitazone and insulin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL133143A0 true IL133143A0 (en) | 2001-03-19 |
Family
ID=10814527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13314398A IL133143A0 (en) | 1997-06-18 | 1998-06-15 | Treatment of diabetes with rosiglitazone and insulin |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0999837A1 (el) |
| JP (1) | JP2002504138A (el) |
| KR (1) | KR20010013843A (el) |
| CN (1) | CN1133431C (el) |
| AP (1) | AP1287A (el) |
| AR (2) | AR012997A1 (el) |
| AU (1) | AU8216398A (el) |
| BG (1) | BG104059A (el) |
| BR (1) | BR9810444A (el) |
| CA (1) | CA2294141A1 (el) |
| CO (1) | CO4940454A1 (el) |
| DZ (1) | DZ2521A1 (el) |
| EA (1) | EA004800B1 (el) |
| GB (1) | GB9712866D0 (el) |
| HU (1) | HUP0003260A3 (el) |
| ID (1) | ID23951A (el) |
| IL (1) | IL133143A0 (el) |
| IN (1) | IN189723B (el) |
| MA (1) | MA26511A1 (el) |
| NO (1) | NO996265L (el) |
| OA (1) | OA11517A (el) |
| PE (1) | PE104499A1 (el) |
| PL (1) | PL343123A1 (el) |
| SK (1) | SK179399A3 (el) |
| TR (1) | TR199903095T2 (el) |
| TW (1) | TW587937B (el) |
| UA (1) | UA70299C2 (el) |
| UY (1) | UY25050A1 (el) |
| WO (1) | WO1998057636A1 (el) |
| ZA (1) | ZA985237B (el) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291495B1 (en) * | 1997-02-24 | 2001-09-18 | Robert B. Rieveley | Method and composition for the treatment of diabetes |
| TWI249401B (en) | 1999-04-14 | 2006-02-21 | Takeda Chemical Industries Ltd | Agent for improving ketosis |
| PT1173434E (pt) | 1999-04-23 | 2003-12-31 | Smithkline Beecham Plc | Novo produto farmaceutico |
| WO2000078333A2 (en) * | 1999-06-21 | 2000-12-28 | Eli Lilly And Company | Synergetic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependant diabetes |
| WO2001000223A2 (en) | 1999-06-25 | 2001-01-04 | Minimed Inc. | Multiple agent diabetes therapy |
| US6468507B1 (en) * | 2000-05-01 | 2002-10-22 | Aeropharm Technology, Inc. | Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
| GB0023970D0 (en) * | 2000-09-29 | 2000-11-15 | Smithkline Beecham Plc | Novel pharmaceutical |
| US6852694B2 (en) | 2001-02-21 | 2005-02-08 | Medtronic Minimed, Inc. | Stabilized insulin formulations |
| US6531461B1 (en) | 2001-06-04 | 2003-03-11 | Louis Obyo Obyo Nelson | Medicament for the treatment of diabetes |
| US20020198203A1 (en) * | 2001-06-07 | 2002-12-26 | Wyeth | Combination of a PTPase inhibitor and a thiazolidinedione agent |
| US6737401B2 (en) | 2001-06-28 | 2004-05-18 | Metronic Minimed, Inc. | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
| MXPA05004743A (es) | 2002-11-08 | 2005-08-03 | Hoffmann La Roche | Derivados 4-alcoxioxazol sustituidos como agonistas ppar. |
| US7264813B2 (en) | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
| CN102389427A (zh) * | 2011-10-10 | 2012-03-28 | 成都恒瑞制药有限公司 | 含有罗格列酮和盐酸西替利嗪的固体口服制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE376829T1 (de) * | 1993-09-15 | 2007-11-15 | Daiichi Sankyo Co Ltd | Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm) |
| JPH11510508A (ja) * | 1995-08-10 | 1999-09-14 | ワーナー−ランバート・コンパニー | インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法 |
| AU725998B2 (en) * | 1995-09-18 | 2000-10-26 | Eisai R&D Management Co., Ltd. | Treating NIDDM with RXR agonists |
-
1997
- 1997-06-18 GB GBGB9712866.4A patent/GB9712866D0/en active Pending
-
1998
- 1998-06-15 CA CA002294141A patent/CA2294141A1/en not_active Abandoned
- 1998-06-15 HU HU0003260A patent/HUP0003260A3/hu unknown
- 1998-06-15 WO PCT/EP1998/003692 patent/WO1998057636A1/en not_active Application Discontinuation
- 1998-06-15 TR TR1999/03095T patent/TR199903095T2/xx unknown
- 1998-06-15 PL PL98343123A patent/PL343123A1/xx unknown
- 1998-06-15 KR KR1019997011864A patent/KR20010013843A/ko not_active Application Discontinuation
- 1998-06-15 ID IDW991627A patent/ID23951A/id unknown
- 1998-06-15 IL IL13314398A patent/IL133143A0/xx unknown
- 1998-06-15 CN CNB988062232A patent/CN1133431C/zh not_active Expired - Fee Related
- 1998-06-15 SK SK1793-99A patent/SK179399A3/sk unknown
- 1998-06-15 UA UA99126881A patent/UA70299C2/uk unknown
- 1998-06-15 JP JP50375799A patent/JP2002504138A/ja not_active Ceased
- 1998-06-15 EP EP98932169A patent/EP0999837A1/en not_active Withdrawn
- 1998-06-15 BR BR9810444-6A patent/BR9810444A/pt not_active IP Right Cessation
- 1998-06-15 EA EA200000042A patent/EA004800B1/ru not_active IP Right Cessation
- 1998-06-15 AU AU82163/98A patent/AU8216398A/en not_active Abandoned
- 1998-06-15 AP APAP/P/1999/001718A patent/AP1287A/en active
- 1998-06-17 AR ARP980102883A patent/AR012997A1/es not_active Application Discontinuation
- 1998-06-17 AR ARP980102886A patent/AR015894A1/es not_active Application Discontinuation
- 1998-06-17 MA MA25122A patent/MA26511A1/fr unknown
- 1998-06-17 ZA ZA9805237A patent/ZA985237B/xx unknown
- 1998-06-17 DZ DZ980131A patent/DZ2521A1/xx active
- 1998-06-17 TW TW087109619A patent/TW587937B/zh not_active IP Right Cessation
- 1998-06-18 IN IN1698DE1998 patent/IN189723B/en unknown
- 1998-06-18 PE PE1998000535A patent/PE104499A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034654A patent/CO4940454A1/es unknown
- 1998-06-18 UY UY25050A patent/UY25050A1/es unknown
-
1999
- 1999-12-17 OA OA9900296A patent/OA11517A/en unknown
- 1999-12-17 NO NO996265A patent/NO996265L/no not_active Application Discontinuation
-
2000
- 2000-01-06 BG BG104059A patent/BG104059A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IN189723B (el) | 2003-04-19 |
| NO996265D0 (no) | 1999-12-17 |
| AR012997A1 (es) | 2000-11-22 |
| UY25050A1 (es) | 2000-09-29 |
| CO4940454A1 (es) | 2000-07-24 |
| ZA985237B (en) | 2000-02-17 |
| MA26511A1 (fr) | 2004-12-20 |
| SK179399A3 (en) | 2000-11-07 |
| EA004800B1 (ru) | 2004-08-26 |
| BR9810444A (pt) | 2000-09-05 |
| AP9901718A0 (en) | 1999-12-31 |
| CN1133431C (zh) | 2004-01-07 |
| NO996265L (no) | 1999-12-17 |
| TR199903095T2 (xx) | 2000-08-21 |
| HUP0003260A2 (hu) | 2001-05-28 |
| EP0999837A1 (en) | 2000-05-17 |
| BG104059A (en) | 2000-10-31 |
| ID23951A (id) | 2000-06-08 |
| GB9712866D0 (en) | 1997-08-20 |
| AR015894A1 (es) | 2001-05-30 |
| CA2294141A1 (en) | 1998-12-23 |
| AU8216398A (en) | 1999-01-04 |
| DZ2521A1 (fr) | 2003-02-08 |
| OA11517A (en) | 2004-02-04 |
| PL343123A1 (en) | 2001-07-30 |
| WO1998057636A1 (en) | 1998-12-23 |
| HUP0003260A3 (en) | 2001-12-28 |
| TW587937B (en) | 2004-05-21 |
| CN1260715A (zh) | 2000-07-19 |
| KR20010013843A (ko) | 2001-02-26 |
| PE104499A1 (es) | 2000-01-13 |
| JP2002504138A (ja) | 2002-02-05 |
| UA70299C2 (en) | 2004-10-15 |
| EA200000042A1 (ru) | 2000-08-28 |
| AP1287A (en) | 2004-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9901719A0 (en) | Treatment of diabetes with thiazolidinedione and metormin | |
| HK1045111A1 (en) | (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes | |
| HUP9902706A3 (en) | Syringe with electronic representation of parameters | |
| PL342517A1 (en) | Methods of treating diabetes employing peptidic insulin analoques | |
| IL133143A0 (en) | Treatment of diabetes with rosiglitazone and insulin | |
| EG21712A (en) | Treatment of insulin resistance | |
| IL127219A0 (en) | The use of insulin sensitivity enhancers for treatment of hyperuricemia and compositions containing insulin sensitivity enhancers for treating the same | |
| AP2000001733A0 (en) | Treatment of diabetes with thiazolidinedione insulin secretagogue and diguanide | |
| EP0832204A4 (en) | TREATMENT OF INSULIN RESISTANCE | |
| IL133907A0 (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor | |
| HK1028200A1 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| AP2000001734A0 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| PL337577A1 (en) | Treatment of diabetes with thiazolydinone and alpha - glucosidaze inhibitor | |
| AU2940895A (en) | Use of insulin and igf-i | |
| AU4073299A (en) | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia | |
| ZA969435B (en) | Treatment of diabetes with a glucokinase gene | |
| HK1042253A1 (zh) | 化合物及其用於治療糖尿病並發症的用途 | |
| HUP0002668A3 (en) | Treatment of diabetes with thiazolidinedione and metformin | |
| HUP0002669A3 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| GB9618290D0 (en) | Treatment of diabetes | |
| IL94241A0 (en) | Diagnosis and treatment of insulin dependent diabetes mellitus | |
| IL121656A0 (en) | Diagnosis prevention and treatment of diabetes | |
| GB9609897D0 (en) | Treatment of diabetes |